Storm Therapeutics
A biotechnology company developing small molecule drugs that target RNA modifying enzymes for the treatment of cancer.
Storm Therapeutics has raised €76M across 2 funding rounds from 10 investors, most recently a Series C round in Apr 2026. Based in Cambridge, UK; active in Healthtech. Data as of 28 Oct 2026.
Cambridge, UKwww.stormtherapeutics.com ↗
Total raised
€76M
€75,701,790
Funding rounds
2
Investors
10
distinct backers
Active since
2022-12
latest 2026-04
Funding by year
EUR raised per year · 2026 YTDStorm Therapeutics — funding by year — interactive chart.
Data table
| Storm Therapeutics — funding by year | |
|---|---|
| 2022 | €28M |
| 2026 | €48M |
Signals
High confidenceRaise-next likelihood53
base rate 50% for Series C
- ▼ Raised very recently
- ▲ Up-round momentum
Exit likelihood19
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ Recently backed by strong-exit-track investors
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-04-16 | Series C | €48M | Fast Track Initiative (FTI),IP Group PLC,M Ventures,Pfizer Ventures,Taiho Ventures,UTokyo Innovation Platform | View deal → |
| 2022-12-14 | Series B | €28M | Cambridge Innovation Capital,Fast Track Initiative,IP Group PLC,M Ventures,Pfizer Ventures,Seroba Life Sciences+2 more | View deal → |
Investors
10Related news
- Storm Therapeutics Closes USD $30M Series B Financingfinsmes.com · 2022-12
- finsmes.com
Similar companies
same sector or countryGlobal coverage: FundingData